American Century Companies’s Madrigal Pharmaceuticals MDGL Stock Holding History

American Century Companies's MDGL Position: Q1 2026 in Review

American Century Companies reduced its Madrigal Pharmaceuticals (MDGL) stake by 11% in Q1 2026, selling an estimated $10.1M and leaving 163,933 shares worth $85.8M. The position accounts for 0.04% of the portfolio, ranked #501.

American Century Companies first reported a position in MDGL in Q2 2018 and has held it in 14 quarters since. The position peaked at $108M in Q4 2025. 378 funds tracked by Wall St. Rank hold MDGL as of Q1 2026.

• American Century Companies held 163,933 shares of Madrigal Pharmaceuticals worth $85.8M as of Q1 2026.
• American Century Companies sold 21,183 Madrigal Pharmaceuticals shares in Q1 2026, an estimated $10.1M.
• Madrigal Pharmaceuticals made up 0.04% of American Century Companies's portfolio in Q1 2026, its #501 holding.
• American Century Companies first reported a position in Madrigal Pharmaceuticals in Q2 2018 and has held it in 14 quarters since.
• American Century Companies's Madrigal Pharmaceuticals position peaked at $108M in Q4 2025.
• 378 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q1 2026.

Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.